Analysis of the Functional Impact of Total Knee Arthroplasty Using Quantified Gait Analysis and Proprioceptive Evaluation
Launched by UNIVERSITY HOSPITAL, GRENOBLE · Mar 26, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how total knee replacement surgery, also known as total knee arthroplasty, affects patients' ability to walk and perform daily activities. The goal is to understand why some patients are not happy with the results of their surgery, even though surgical techniques have improved over the years. Researchers will use detailed measurements of walking and daily tasks, along with patient feedback, to find out what factors might lead to dissatisfaction after the surgery.
To participate in this trial, you need to be an adult with a specific type of knee problem called gonarthrosis, which means you have arthritis affecting your knee. You should also be scheduled for a total knee replacement. However, if you have certain conditions that affect your balance or ability to move, or if you have significant difficulties with daily activities, you may not be eligible. The trial is not currently recruiting participants, but it aims to provide important insights that could improve outcomes for future patients undergoing this surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patient
- • Gonarthrosis on imaging with indication for total knee arthroplasty (TKA)
- • Isolated gonarthrosis
- Exclusion Criteria:
- • Patient objecting to study participation
- • Patient with an associated pathology causing balance and/or proprioceptive disorders (Parkinson's, stroke sequelae, etc.).
- • Patients with a history of cognitive disorders, either confirmed or currently being assessed.
- • IADL score below 3, indicating major dependence in daily life.
- • Patients unable to walk without technical aids for 6 months.
- • Patients unable to get up from a chair without armrests
- • Parker score below 6
- • Protected persons covered by articles L1121-5 to L1121-8 of the French Public Health Code
About University Hospital, Grenoble
The University Hospital of Grenoble is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. As a prominent sponsor of clinical trials, the hospital leverages its expertise in various medical disciplines to facilitate cutting-edge studies that aim to improve treatment outcomes and enhance patient safety. With a strong commitment to collaboration, the University Hospital of Grenoble engages in partnerships with academic institutions, industry leaders, and regulatory bodies to drive scientific discovery and translate research findings into clinical practice. Its state-of-the-art facilities and multidisciplinary teams ensure rigorous adherence to ethical standards and regulatory guidelines, fostering an environment where groundbreaking research can thrive.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Grenoble, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported